Don't miss a thing!

OUR NEWS AND VIEWS

SHARING LATEST
DEVELOPMENTS AND INSIGHTS

Here we report on topics relating to digital medical publishing and our business. These include our research reports, whitepapers and thought-leadership, as well as our latest programmes, engagement insights, industry partnerships and team recruits.

Categories

Announcements

May 2023

Growth Hormone Deficiency Learning Zone launches on Medthority

HCPs will gain understanding of growth hormone deficiency and appropriate treatment options after engaging with this educational programme, developed independently of sponsor Sandoz.

View the Learning Zone
Announcements

May 2023

Programme goes live: Anti-CGRP therapies for migraine

Developed with an educational grant from Pfizer, this Learning Zone includes focus on the unmet needs and disease burden associated with migraine and anti-CGRP therapies for acute and prophylactic treatment.

View the Learning Zone
Thought Leadership

Apr 2023

Harnessing the power of omnichannel for impactful HCP engagement

Are you making best use of available channels to deliver meaningful engagement with HCPs? In this article, we offer insight on the building blocks for an effective omnichannel approach.

READ ARTICLE

Featured article

Thought Leadership

Creating an award-winning HCP engagement platform

EPG Health’s pioneering approach to…

Learn More

Jan 2023

Thought Leadership

Mar 2023

The evolution of medical congress – where next?

Following the emergence of the hybrid congress model, EPG Health shares expert insight into the future of scientific meetings and opportunities that have surfaced to expand their reach far beyond in-person attendance.

READ ARTICLE
Announcements

Feb 2023

Programme launch: Weight control in type 2 diabetes

With an educational grant from Eli Lilly & Company, EPG Health has launched an independent Learning Zone (featuring KOL videos) to enhance disease awareness and educate HCPs on treatment and strategies for prevention.

View the Learning Zone
Announcements

Feb 2023

Launch of mCRPC Learning Zone on Medthority

Developed independently of sponsor Pfizer, this programme details unmet needs in the management of metastatic castration-resistant prostate cancer and potential ways to meet them, featuring expert opinion from KOLs and congress highlights.

View the Learning Zone